Navigation Links
Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrig's Disease (ALS)
Date:6/23/2011

neurological illness could make donations that can support investigator-initiated clinical trials. The Center hopes to optimize proper treatments in order to improve outcomes for patients with neurological diseases. For more information on the Center, please visit its website at www.pnaresearch.org.

About AEN-100 and AEN-200

AEN-100 is Adeona's proprietary, once-daily, gastroretentive, sustained-release oral tablet formulation of zinc acetate. AEN-200 is Adeona's proprietary oral tablet formulation of copper sulfate.

About Adeona Pharmaceuticals, Inc.

Adeona is a pharmaceutical company developing innovative medicines for the treatment of serious central nervous system diseases. The Company's primary strategy is to license product candidates that have demonstrated a certain level of clinical efficacy and develop them to a stage that results in a significant commercial collaboration. Currently, Adeona is preparing to make reaZinTM, a prescription medical food for the dietary management of zinc deficiency associated with Alzheimer's disease, commercially available. In addition, the Company is developing, or has partnered the development of, drug product candidates to treat multiple sclerosis, fibromyalgia, amyotrophic lateral sclerosis (ALS), Alzheimer's disease and age-related macular degeneration. For more information, please visit Adeona's website at www.adeonapharma.com.

RILUTEK® (riluzole) is a registered trademark of sanofi-aventis U.S. LLC.

This release includes forward-looking statements on Adeona's current expectations and projections about future events. In some cases forward-looking statements can be identified by terminology such as "may," "could," "potential," "positions," "continue," "expects," "anticipates," "intends," "plans," "believe," "estimates," and similar expressions. These stateme
'/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Adeona Announces HartLab Expansion Into Microbiology Testing Services
2. Adeona Completes Equity Financing and Provides Alzheimers Disease Clinical Study Update
3. Adeona Announces Second Quarter 2010 Profitability and Achievements
4. Adeona Announces Five Scientific Publications on Role of Copper Toxicity and Zinc Deficiency in Alzheimers Disease and Cognitive Decline
5. Adeona CEO to Provide Keynote Address at the 2010 MichBio Expo & Conference Emerging Biosciences Showcase
6. Adeona to Hold Annual Shareholder Meeting
7. Adeona Announces Third Quarter 2010 Financial Results and Achievements
8. Adeona Acquires Access to Clinical Data Supporting Oral Zinc for Prevention of Infections in the Elderly
9. Adeona to Present at OneMedForum San Francisco 2011 Conference
10. Adeona to Host Investor Day on Zinc Deficiency in Alzheimers Disease
11. Adeona to Raise $4 Million in Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015 Research and Markets ( ... "The Corporate Reputation of Pharma - The ... report to their offering. The ... now in its fourth edition. This report contains ... For each annual Corporate Reputation report, the author ...
(Date:4/16/2015)... 16, 2015 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... development and commercialization of products for the treatment of ... results for the first quarter of 2015 on Wednesday, ... The Company will host a conference call at ... which Vanda management will discuss the first quarter 2015 ...
(Date:4/16/2015)... , April 16, 2015  Amgen (NASDAQ: ... first quarter financial results on Tuesday, April 21, 2015, ... announcement will be followed by a conference call with ... the call from Amgen will be Robert A. ... members of Amgen,s senior management team. Live ...
Breaking Medicine Technology:The Corporate Reputation of Pharma - The Global Patient Perspective in 2014 2Vanda Pharmaceuticals to Announce First Quarter 2015 Financial Results on May 6, 2015 2Amgen Announces Webcast Of 2015 First Quarter Financial Results 2
... DIEGO and WOODCLIFF LAKE, N.J., Aug. 2, 2011 Arena ... announced today the completion of a clinical study ... plasma and related data analyses. The study was conducted to ... human relevance of the observation of brain astrocytoma in male ...
... Aug. 1, 2011 Diabetes company Novo Nordisk, ... Equities and LCOR in partnership with Intercontinental Real ... project to completely renovate and upgrade a 770,000-square-foot ... Plainsboro, N.J., that will serve as the new ...
Cached Medicine Technology:Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses 2Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses 3Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses 4Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses 5Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses 6Novo Nordisk and Partnership of Ivy Equities, LCOR and Intercontinental RE Corp. Announce Lease Agreement for N.J. Pharmaceutical Company's New U.S. Headquarters 2Novo Nordisk and Partnership of Ivy Equities, LCOR and Intercontinental RE Corp. Announce Lease Agreement for N.J. Pharmaceutical Company's New U.S. Headquarters 3Novo Nordisk and Partnership of Ivy Equities, LCOR and Intercontinental RE Corp. Announce Lease Agreement for N.J. Pharmaceutical Company's New U.S. Headquarters 4Novo Nordisk and Partnership of Ivy Equities, LCOR and Intercontinental RE Corp. Announce Lease Agreement for N.J. Pharmaceutical Company's New U.S. Headquarters 5
(Date:4/19/2015)... 19, 2015 Women’s Excellence , ... Metamora (Michigan), now offers pelvic organ prolapse treatment. ... connecting tissue (fascia), and thickened pieces of fascia that ... the fascia and ligaments have to bear the brunt ... allowing pelvic organs to drop and press into the ...
(Date:4/19/2015)... The American Association for Physician Leadership® ... the inaugural winner of the Roger Schenke Award. The ... 18, in Las Vegas, Nevada. , Ellner, president ... the department of surgery and director of surgical quality ... Connecticut, was instrumental in the founding of the Connecticut ...
(Date:4/19/2015)... Lowcostcarinsuranceprice.com has released a new blog post ... arrested for DUI. The blog post also discusses the ... , Some pills can have dangerous side effects ... are under medication should ask their doctor’s advice before ... be considered driving under the influence and clients can ...
(Date:4/19/2015)... New court documents issued by the ... Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ) continue to mount in ... of South Carolina. According to the April 15th filing, ... the proceeding on behalf of individuals who allegedly developed ... cholesterol-lowering statin. This represents an increase of 110 filings ...
(Date:4/19/2015)... (PRWEB) April 19, 2015 McCann Investigations, ... to announce the publication of white paper Married, ... . As online media provides a unique environment ... niche market specifically targeting adulterous spouses has emerged. ... affair becomes as easy as shopping online. Dating ...
Breaking Medicine News(10 mins):Health News:Women's Excellence Now Offers Pelvic Organ Prolapse Treatment 2Health News:Dr. Scott Ellner named inaugural Roger Schenke Award winner 2Health News:Dr. Scott Ellner named inaugural Roger Schenke Award winner 3Health News:Driving On Medication - Possible Effects On Auto Insurance Prices 2Health News:Lipitor Lawsuits Mount, as New Court Report Shows More Than 100 Filings Added to Federal Litigation Since March 2Health News:Lipitor Lawsuits Mount, as New Court Report Shows More Than 100 Filings Added to Federal Litigation Since March 3Health News:McCann Investigations Publishes White Paper Married, but Dating: The Rise of the Married Online Affair 2
... has negatively affected the treatment received by children and adolescents ... The meeting was hosted in association with the European Society ... hurdles faced by patients and those who care for them ... The Directive (2001/20/EC) has been one of the most ...
... 2012) The Scott & White Heart & Vascular Institute ... of Approval as a hospital performing Ventricular Assist Device ... permanent support for end stage heart failure by means ... the program demonstrated compliance with The Joint Commission,s national ...
... Gordon HealthDay Reporter , TUESDAY, Feb. 14 ... doesn,t speed recovery, new research shows. "We did ... diagnosis of acute sinusitis, and found no benefit from ... of acute sinusitis," said study author Dr. Jane Garbutt, ...
... , TUESDAY, Feb. 14 (HealthDay News) -- People who drank ... to 5 pounds over half a year, according to new ... divided into three groups: those who switched to water from ... those who weren,t advised to change beverages but were given ...
... , Blood tests have been a mainstay of diagnostic ... of information concerning health and disease. Nevertheless, blood derived ... fully mined for its vital health information, according to ... Institute. In a new study appearing in the ...
... in the field of Physical Anthropology. She not only ... Czech Republic, but she is also the Chair of ... the Department of Genetics, Physical Anthropology and Animal Physiology ... carried out numerous pieces of work into nutritional habits, ...
Cached Medicine News:Health News:Calls for policy changes as lives put at risk by bureaucracy 2Health News:Calls for policy changes as lives put at risk by bureaucracy 3Health News:Antibiotics Don't Help Most Sinus Infections, Study Finds 2Health News:Antibiotics Don't Help Most Sinus Infections, Study Finds 3Health News:Switching to Water, Diet Drinks Linked to Modest Weight Loss 2Health News:Following a trail of blood: A new diagnostic tool comes of age 2Health News:Following a trail of blood: A new diagnostic tool comes of age 3Health News:Analyzing the causes of obesity in the Romani ethnic group 2Health News:Analyzing the causes of obesity in the Romani ethnic group 3
... V measures prompt ... luminescence, time-resolved ... A red-sensitive PMT ... All technologies needed ...
This a new dedicated VICTOR2 model for fluorescence and luminescence detection with stacker and robotic loading....
... is the modular VICTOR2 ... high density TR-fluorometry, stacker ... The extra high density ... excitation beam for TRF ...
This is the modular manually operated VICTOR2 multilabel counter, with the addition of a xenon flash lamp for time-resolved fluorescence counting. Along with this option comes flash absorbance and du...
Medicine Products: